ClinicalTrials.gg
CompletedNCT06364137Updated Nov 12, 2026Results posted

Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings

An interventional study of Teleo and Standard videoconferencing in Anxiety Disorders and Mood Disorders, sponsored by Stanford University. Completed at 1 site in United States. Open to participants aged 5 Years to 14 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Stanford University · Not applicable, Interventional, and Health services research

How we know

Updated Nov 12, 2026Results postedStudy documents posted+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
5 Years to 14 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 53 studies in Anxiety Disorders by Stanford University — 7 open to participants now, 9 under way, none of them phase 3. Anxiety Disorders · Stanford University.

Enrollment
22nd of 47
56 · median 51
Started
2024
with 3 others
No phase
47 of 53
6 open now
Registered
42nd of 53
by date

Among the 53 studies in Anxiety Disorders by Stanford University, this one is the 22nd largest by enrollment of the 47 interventional ones that give a count, is one of 4 that started in 2024, is one of 47 with no phase, and was the 42nd registered.

Anxiety Disorders

7,249 studies on the registry are indexed under Anxiety Disorders; 1,691 are open to participants now.

Browse Anxiety Disorders studies →

Open to participants now

7 of the 53 studies in Anxiety Disorders by Stanford University are open now, in 1 country. Recruiting first, the newest first:

2 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 947 Anxiety Disorders studies recruiting now, 423 (45%) set no upper age limit and 455 (48%) stop at 75 or younger; 233 take children under 18; 319 take healthy volunteers.

This study: 5 Years to 14 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 53 studies in Anxiety Disorders by Stanford University, or all of them as a file.
02

Study summary

The research study will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the pilot trial will examine examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.

Read the detailed description

The research study will examine engagement in telehealth for children undergoing psychotherapy. The study in Phase I entails a pilot randomized trial with a goal to enroll children from 42 families and their therapists, examining patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.

Engagement will be assessed using well-established measures - CIRS (modified) video coding (session 1), MTT-Y/MTTCG (sessions 1, 4) and attendance data (sessions 1-4). Clinicians in the study will deliver therapy to clients for 4 sessions, providing opportunity to measure temporal sustainment of any engagement differences.

03

Conditions studied

  • Anxiety Disorders
  • Mood Disorders
04

Who can participate

Ages eligible
5 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Receiving psychotherapy with a licensed professional on the Teleo platform
  • Likely have at least 12 sessions remaining.
  • Diagnosis of a mental health condition by a licensed clinician

Exclusion criteria

Exclusion Criteria:

  • Not under treatment with provider using Teleo platform
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
56 participants (actual)

Study arms

  • Experimental
    Teleo

    Participants in this group will undergo therapy for 4 sessions using the Teleo virtual therapy video platform, sessions will be recorded and questionnaires and clinical data will be measured.

    Other: Teleo

  • Active comparator
    Standard videoconferencing

    Participants in this group will undergo therapy for 4 sessions using standard video platforms (e.g. zoom or other publicly available product), sessions will be recorded and questionnaires and clinical data will be measured.

    Other: Standard videoconferencing

Interventions

  • OtherTeleo

    Therapist-led psychotherapy sessions implemented within the Teleo virtual therapy platform.

  • OtherStandard videoconferencing

    Therapist-led psychotherapy sessions implemented in standard (non-Teleo) video platform

06

What researchers measure

Primary outcomes

  1. Child Involvement Rating Scale (CIRS)

    The Child Involvement Rating Scale (CIRS) is a 10-item observer-rated measure of child engagement in therapy. Each item is rated on a 6-point Likert scale ranging from 0 (No presence) to 5 (A great deal). Six items (initiating discussion, suggesting task changes, enthusiastic participation, self-disclosure, asking questions, and elaboration) assess positive therapeutic engagement, where a higher score indicates greater engagement. The four remaining items (withdrawal, avoidance, distraction, and oppositionality) assess disengagement-related behaviors, where a higher score indicates greater disengagement. The six engagement items are directly scored (a rating of 0 is scored as 0, and a rating of 5 is scored as 5). The four disengagement items are reverse-scored (a rating of 0 is scored as 5, and a rating of 5 is scored as 0). All 10 item scores are summed to produce a CIRS total score ranging from 0 to 50. Higher total scores indicate greater child engagement (better outcomes).

    Time frame: Week 1

Secondary outcomes

  1. My Thoughts About Therapy - Caregiver (MTT-CG)

    The My Thoughts About Therapy Questionnaire - Caregiver Version (MTT-CG) is a 35-item questionnaire with 5 subscales, each with 7 items, that represent the multidimensional REACH framework for characterizing treatment engagement: Relationship, Expectancy, Attendance, Clarity, and Homework (Becker et al., 2018). Items are rated on a 4-point Likert-scale from 0 ("strongly disagree") to 3 ("strongly agree"). To score the MTT, each item is assigned a numerical value from 0-3, where 0 = strongly disagree, 1 = disagree, 2 = agree, and 3 = strongly agree. For each subscale add the numerical values for each of the 7 items together. Thus, the highest subscale score possible is 21, the lowest 0. The total score is calculated as the sum of the 5 subscale scores, with a maximum possible score of 105 and a minimum possible score of 0.

    Time frame: Weeks 1 and 4

  2. My Thoughts About Therapy - Youth Version (MTT-Y)

    The My Thoughts About Therapy Questionnaire - Youth Version (MTT-Y) is a 35-item questionnaire with 5 subscales, each with 7 items, that represent the multidimensional REACH framework for characterizing treatment engagement: Relationship, Expectancy, Attendance, Clarity, and Homework (Becker et al., 2018). Items are rated on a 4-point Likert-scale from 0 ("strongly disagree") to 3 ("strongly agree"). To score the MTT, each item is assigned a numerical value from 0-3, where 0 = strongly disagree, 1 = disagree, 2 = agree, and 3 = strongly agree. For each subscale add the numerical values for each of the 7 items together. Thus, the highest subscale score possible is 21, the lowest 0. The total score is calculated as the sum of the 5 subscale scores, with a maximum possible score of 105 and a minimum possible score of 0.

    Time frame: Weeks 1 and 4

  3. Psychotherapy Session Attendance

    Clinicians recorded attendance for each of the 4 scheduled therapy sessions (Weeks 1-4) on an attendance form, categorizing each session as attended on time, attended late (10+ minutes), rescheduled/cancelled, no-show, or treatment dropout. The reported value is the number of sessions attended on time in each arm, calculated as a single pooled proportion across participants: the number of sessions attended on time divided by the number of scheduled sessions for all participants in that arm. Values range from 0 to 1, with higher values indicating better attendance.

    Time frame: Weeks 1-4

07

Results

Posted Nov 12, 2026

Participant flow

Participants were recruited from therapists in private practice already using the Teleo platform. If the family indicated to their therapist that they were willing to be contacted for research activities, they were approached by the research team, via in-person contact, telephone or other method, for a consultation regarding the study. Eligibility was determined based on inclusion/exclusion criteria.

Participant flow — Overall Study
MilestoneTeleoStandard VideoconferencingTherapists
Started202214
Completed192013
Not completed121
Withdrew: Withdrawal by subject011
Withdrew: Child's therapist dropped out of study110

Outcome measures

PrimaryChild Involvement Rating Scale (CIRS)

The Child Involvement Rating Scale (CIRS) is a 10-item observer-rated measure of child engagement in therapy. Each item is rated on a 6-point Likert scale ranging from 0 (No presence) to 5 (A great deal). Six items (initiating discussion, suggesting task changes, enthusiastic participation, self-disclosure, asking questions, and elaboration) assess positive therapeutic engagement, where a higher score indicates greater engagement. The four remaining items (withdrawal, avoidance, distraction, and oppositionality) assess disengagement-related behaviors, where a higher score indicates greater disengagement. The six engagement items are directly scored (a rating of 0 is scored as 0, and a rating of 5 is scored as 5). The four disengagement items are reverse-scored (a rating of 0 is scored as 5, and a rating of 5 is scored as 0). All 10 item scores are summed to produce a CIRS total score ranging from 0 to 50. Higher total scores indicate greater child engagement (better outcomes).

Time frame:
Week 1
Reported as:
Mean · Scores on a Scale
Child Involvement Rating Scale (CIRS)
Scores on a ScaleTeleoStandard Videoconferencing
Child Involvement Rating Scale (CIRS)36.80 ± 1032.90 ± 12.71
Statistical analysis
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = 0.456 · Mean difference (final values): 3.90 · 95% CI -6.89 to 14.69
SecondaryMy Thoughts About Therapy - Caregiver (MTT-CG)

The My Thoughts About Therapy Questionnaire - Caregiver Version (MTT-CG) is a 35-item questionnaire with 5 subscales, each with 7 items, that represent the multidimensional REACH framework for characterizing treatment engagement: Relationship, Expectancy, Attendance, Clarity, and Homework (Becker et al., 2018). Items are rated on a 4-point Likert-scale from 0 ("strongly disagree") to 3 ("strongly agree"). To score the MTT, each item is assigned a numerical value from 0-3, where 0 = strongly disagree, 1 = disagree, 2 = agree, and 3 = strongly agree. For each subscale add the numerical values for each of the 7 items together. Thus, the highest subscale score possible is 21, the lowest 0. The total score is calculated as the sum of the 5 subscale scores, with a maximum possible score of 105 and a minimum possible score of 0.

Time frame:
Weeks 1 and 4
Reported as:
Mean · Participants' scores on the MTT-CG
My Thoughts About Therapy - Caregiver (MTT-CG)
Participants' scores on the MTT-CGTeleoStandard Videoconferencing
MTT-CG Total Score (Week 1)82.44 ± 11.3585.76 ± 11.80
MTT-CG Total Score (Week 4)86.72 ± 11.7787.76 ± 11.82
MTT-CG Relationship Subscale Score (Week 1)18.56 ± 3.1519.24 ± 2.84
MTT-CG Relationship Subscale Score (Week 4)18.72 ± 2.8919.71 ± 2.28
MTT-CG Expectancy Subscale Score (Week 1)17.78 ± 2.5618.06 ± 2.19
MTT-CG Expectancy Subscale Score (Week 4)18.78 ± 1.9018.59 ± 2.37
MTT-CG Attendance Subscale Score (Week 1)15.50 ± 2.0715.18 ± 2.77
MTT-CG Attendance Subscale Score (Week 4)16.22 ± 2.3215.71 ± 3.41
MTT-CG Clarity Subscale Score (Week 1)16.33 ± 3.1117.41 ± 3.87
MTT-CG Clarity Subscale Score (Week 4)17.11 ± 3.8617.06 ± 4.13
MTT-CG Homework Subscale Score (Week 1)14.28 ± 2.9915.88 ± 2.98
MTT-CG Homework Subscale Score (Week 4)15.89 ± 3.5316.71 ± 3.00
Statistical analysis
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = 0.402 · Mean difference (final values): -3.32 · 95% CI -11.29 to 4.65Positive parameter values indicate higher scores in the Teleo condition relative to Standard videoconferencing.
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = 0.795 · Mean difference (final values): -1.04 · 95% CI -9.16 to 7.07Positive parameter values indicate higher scores in the Teleo condition relative to Standard videoconferencing.
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = 0.506 · Mean difference (final values): -0.68 · 95% CI -2.73 to 1.38Positive parameter values indicate higher scores in the Teleo condition relative to Standard videoconferencing.
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = 0.270 · Mean difference (final values): -0.98 · 95% CI -2.77 to 0.80
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = 0.729 · Mean difference (final values): -0.28 · 95% CI -1.92 to 1.35
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = 0.797 · Mean difference (final values): 0.19 · 95% CI -1.29 to 1.68
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = 0.699 · Mean difference (final values): 0.32 · 95% CI -1.37 to 2.02Positive parameter values indicate higher scores in the Teleo condition relative to Standard videoconferencing.
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = 0.606 · Mean difference (final values): 0.52 · 95% CI -1.51 to 2.54
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = 0.372 · Mean difference (final values): -1.08 · 95% CI -3.51 to 1.35
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = 0.969 · Mean difference (final values): 0.05 · 95% CI -2.70 to 2.81
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = 0.121 · Mean difference (final values): -1.60 · 95% CI -3.66 to 0.45
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = 0.465 · Mean difference (final values): -0.82 · 95% CI -3.06 to 1.43
SecondaryMy Thoughts About Therapy - Youth Version (MTT-Y)

The My Thoughts About Therapy Questionnaire - Youth Version (MTT-Y) is a 35-item questionnaire with 5 subscales, each with 7 items, that represent the multidimensional REACH framework for characterizing treatment engagement: Relationship, Expectancy, Attendance, Clarity, and Homework (Becker et al., 2018). Items are rated on a 4-point Likert-scale from 0 ("strongly disagree") to 3 ("strongly agree"). To score the MTT, each item is assigned a numerical value from 0-3, where 0 = strongly disagree, 1 = disagree, 2 = agree, and 3 = strongly agree. For each subscale add the numerical values for each of the 7 items together. Thus, the highest subscale score possible is 21, the lowest 0. The total score is calculated as the sum of the 5 subscale scores, with a maximum possible score of 105 and a minimum possible score of 0.

Time frame:
Weeks 1 and 4
Reported as:
Mean · Participants' MTT-Y Scores
My Thoughts About Therapy - Youth Version (MTT-Y)
Participants' MTT-Y ScoresTeleoStandard Videoconferencing
MTT-Y Total Scores (Week 1)83.56 ± 12.7981.00 ± 9.86
MTT-Y Total Scores (Week 4)89.56 ± 9.4782.12 ± 12.75
MTT-Y Relationship Subscale Scores (Week 1)17.75 ± 2.7918.00 ± 2.85
MTT-Y Relationship Subscale Scores (Week 4)19.22 ± 2.2617.76 ± 2.99
MTT-Y Expectancy Subscale Scores (Week 1)17.19 ± 2.6116.27 ± 1.98
MTT-Y Expectancy Subscale Scores (Week 4)18.33 ± 2.5416.59 ± 3.08
MTT-Y Attendance Subscale Scores (Week 1)14.81 ± 2.6114.40 ± 2.16
MTT-Y Attendance Subscale Scores (Week 4)15.61 ± 2.7713.88 ± 2.98
MTT-Y Clarity Subscale Scores (Week 1)16.88 ± 3.4616.20 ± 3.12
MTT-Y Clarity Subscale Scores (Week 4)18.56 ± 2.5716.76 ± 3.47
MTT-Y Homework Subscale Scores (Week 1)16.94 ± 3.0016.13 ± 2.85
MTT-Y Homework Subscale Scores (Week 4)17.83 ± 2.3817.12 ± 3.50
Statistical analysis
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = 0.536 · Mean difference (final values): 2.56 · 95% CI -5.80 to 10.93
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = .060 · Mean difference (final values): 7.44 · 95% CI -0.35 to 15.23
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = 0.807 · Mean difference (final values): -0.25 · 95% CI -2.33 to 1.83
  • Teleo · t-test, 2 sided · p = 0.116 · Mean difference (final values): 1.46 · 95% CI -0.38 to 3.30
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = 0.277 · Mean difference (final values): 0.92 · 95% CI -0.77 to 2.62
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = 0.078 · Mean difference (final values): 1.75 · 95% CI -0.21 to 3.70
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = 0.635 · Mean difference (final values): 0.41 · 95% CI -1.35 to 2.17
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = 0.085 · Mean difference (final values): 1.73 · 95% CI -0.25 to 3.70
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = 0.573 · Mean difference (final values): 0.68 · 95% CI -1.74 to 3.09Positive parameter values indicate higher scores in the Teleo condition relative to Standard videoconferencing.
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = 0.094 · Mean difference (final values): 1.79 · 95% CI -0.33 to 3.91Positive parameter values indicate higher scores in the Teleo condition relative to Standard videoconferencing.
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = 0.450 · Mean difference (final values): 0.80 · 95% CI -1.34 to 2.95Positive parameter values indicate higher scores in the Teleo condition relative to Standard videoconferencing.
  • Teleo vs Standard Videoconferencing · t-test, 2 sided · p = 0.488 · Mean difference (final values): 0.71 · 95% CI -1.37 to 2.80Positive parameter values indicate higher scores in the Teleo condition relative to Standard videoconferencing.
SecondaryPsychotherapy Session Attendance

Clinicians recorded attendance for each of the 4 scheduled therapy sessions (Weeks 1-4) on an attendance form, categorizing each session as attended on time, attended late (10+ minutes), rescheduled/cancelled, no-show, or treatment dropout. The reported value is the number of sessions attended on time in each arm, calculated as a single pooled proportion across participants: the number of sessions attended on time divided by the number of scheduled sessions for all participants in that arm. Values range from 0 to 1, with higher values indicating better attendance.

Time frame:
Weeks 1-4
Reported as:
Number · Sessions attended on time
Psychotherapy Session Attendance
Sessions attended on timeTeleoStandard Videoconferencing
Psychotherapy Session Attendance0.93 (0.85 to 0.97)0.89 (0.80 to 0.94)
Statistical analysis
  • Teleo vs Standard Videoconferencing · Chi-squared · p = 0.370 · Difference in proportions: 0.042 · 95% CI -0.05 to 0.13A positive parameter indicates a higher proportion of sessions attended on-time in the Teleo condition.

Adverse events

Collected over From enrollment through completion of the participant off-boarding survey, with a median duration of approximately 16 weeks and a maximum observed duration of 27 weeks.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Teleo0/20 (0%)0/20 (0%)0/20 (0%)
Standard Videoconferencing0/22 (0%)0/22 (0%)0/22 (0%)
Therapists0/13 (0%)0/13 (0%)0/13 (0%)

Baseline characteristics

Treating therapists were consented because they were recorded in videos and completed attendance reports, but no data were collected from them.

Age, Categorical
Age, Categorical(Participants)TeleoStandard VideoconferencingTherapistsTotal
<=18 years2022—42
Between 18 and 65 years00—0
>=65 years00—0
Sex: Female, Male
Sex: Female, Male(Participants)TeleoStandard VideoconferencingTherapistsTotal
Female1211—23
Male811—19
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)TeleoStandard VideoconferencingTherapistsTotal
Hispanic or Latino21—3
Not Hispanic or Latino1820—38
Unknown or Not Reported01—1
Race (NIH/OMB)
Race (NIH/OMB)(Participants)TeleoStandard VideoconferencingTherapistsTotal
American Indian or Alaska Native01—1
Asian10—1
Native Hawaiian or Other Pacific Islander00—0
Black or African American01—1
White1516—31
More than one race33—6
Unknown or Not Reported11—2
Revised Child Anxiety and Depression Scale - Parent Version (RCADS-P)
Revised Child Anxiety and Depression Scale - Parent Version (RCADS-P)(T-score)TeleoStandard VideoconferencingTherapistsTotal
Mean57.58 ± 10.7660.58 ± 14.86—59.07 ± 12.89
08

Study locations

1 site
  • Stanford University
    Stanford, California 94305, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2024 to primary completion in Aug 2025, 13 months.

Results were first posted in Nov 2026, 1 year 2 months after primary completion.

Of 3,871 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's 13 months is close to that.

Counting every sponsor, half of 3,976 studies reached it within 12 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 8, 2024
First posted
Apr 15, 2024
StartActual
Jul 1, 2024
Primary completionActual
Aug 15, 2025
CompletionActual
Sep 15, 2025
Results first posted
Nov 12, 2026
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Nov 12, 2026
Enrollment
41→56
Nov 12, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • ChangedBefore PRIME-O Video Coding ScoreNow Child Involvement Rating Scale (CIRS)Time frame: Weeks 1, 2, 3, 4 → Week 1
Nov 12, 2026
Secondary outcomes
3 edited
What changed in the outcomes
  • EditedMy Thoughts aboutAbout Therapy - Caregiver (MTT-CG) engagement questionnaire scoresTime frame: Post-intervention (at one month) → Weeks 1 and 4
  • EditedMy Thoughts aboutAbout Therapy - Youth Version (MTT-Y) engagement questionnaire scoresTime frame: Post-intervention (at one month) → Weeks 1 and 4
  • ChangedBefore Attendance during Psychotherapy SessionsNow Psychotherapy Session AttendanceTime frame: One month → Weeks 1-4
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    Results posted
    Enrollment 41→56
    Primary outcomes 1 edited
    What changed in the outcomes
    • ChangedBefore PRIME-O Video Coding ScoreNow Child Involvement Rating Scale (CIRS)Time frame: Weeks 1, 2, 3, 4 → Week 1
    Secondary outcomes 3 edited
    What changed in the outcomes
    • EditedMy Thoughts aboutAbout Therapy - Caregiver (MTT-CG) engagement questionnaire scoresTime frame: Post-intervention (at one month) → Weeks 1 and 4
    • EditedMy Thoughts aboutAbout Therapy - Youth Version (MTT-Y) engagement questionnaire scoresTime frame: Post-intervention (at one month) → Weeks 1 and 4
    • ChangedBefore Attendance during Psychotherapy SessionsNow Psychotherapy Session AttendanceTime frame: One month → Weeks 1-4
    + 3 other changes: verification date, description and arm descriptions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT06364137
Collaborators
National Institute of Mental Health (NIMH), MainSquare Co. (dba 'Teleo')
Responsible party
David Hong (Associate Professor of Psychiatry and Behavioral Sciences, Stanford University) — Principal investigator
First posted
Apr 15, 2024
Start date
Jul 1, 2024
Primary completion
Aug 15, 2025
Completion
Sep 15, 2025
Results posted
Nov 12, 2026
Last update
Nov 12, 2026

Study contacts

David S Hong, MD
principal investigator · Stanford University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion